These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
262 related items for PubMed ID: 9986719
21. 4-(tetralin-1-yl)- and 4-(naphthalen-1-yl)alkyl derivatives of 1-cyclohexylpiperazine as sigma receptor ligands with agonist sigma2 activity. Berardi F, Ferorelli S, Abate C, Colabufo NA, Contino M, Perrone R, Tortorella V. J Med Chem; 2004 Apr 22; 47(9):2308-17. PubMed ID: 15084129 [Abstract] [Full Text] [Related]
22. Synthesis of (+)-(R)- and (-)-(S)-trans-8-hydroxy-2-[N-n-propyl-N-(3'-iodo-2'-propenyl)] aminotetralin: new 5-HT1A receptor ligands. Zhuang ZP, Kung MP, Clarke W, Maayani S, Mu M, Kung HF. Chirality; 1995 Apr 22; 7(6):452-8. PubMed ID: 7577352 [Abstract] [Full Text] [Related]
23. New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation. Fiorino F, Perissutti E, Severino B, Santagada V, Cirillo D, Terracciano S, Massarelli P, Bruni G, Collavoli E, Renner C, Caliendo G. J Med Chem; 2005 Aug 25; 48(17):5495-503. PubMed ID: 16107148 [Abstract] [Full Text] [Related]
24. Synthesis and structure-activity relationships of a new model of arylpiperazines. 3.1 2-[omega-(4-arylpiperazin-1-yl)alkyl]perhydropyrrolo- [1,2-c]imidazoles and -perhydroimidazo[1,5-a]pyridines: study of the influence of the terminal amide fragment on 5-HT1A affinity/selectivity. López-Rodríguez ML, Morcillo MJ, Fernández E, Porras E, Murcia M, Sanz AM, Orensanz L. J Med Chem; 1997 Aug 01; 40(16):2653-6. PubMed ID: 9258372 [Abstract] [Full Text] [Related]
25. Orally active benzamide antipsychotic agents with affinity for dopamine D2, serotonin 5-HT1A, and adrenergic alpha1 receptors. Reitz AB, Baxter EW, Codd EE, Davis CB, Jordan AD, Maryanoff BE, Maryanoff CA, McDonnell ME, Powell ET, Renzi MJ, Schott MR, Scott MK, Shank RP, Vaught JL. J Med Chem; 1998 Jun 04; 41(12):1997-2009. PubMed ID: 9622541 [Abstract] [Full Text] [Related]
26. Synthesis and Pharmacology of the enantiomers of the potential atypical antipsychotic agents 5-OMe-BPAT and 5-OMe-(2,6-di-OMe)-BPAT. Homan EJ, Copinga S, Unelius L, Jackson DM, Wikström HV, Grol CJ. Bioorg Med Chem; 1999 Jul 04; 7(7):1263-71. PubMed ID: 10465402 [Abstract] [Full Text] [Related]
28. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity. Hirokawa Y, Fujiwara I, Suzuki K, Harada H, Yoshikawa T, Yoshida N, Kato S. J Med Chem; 2003 Feb 27; 46(5):702-15. PubMed ID: 12593651 [Abstract] [Full Text] [Related]
30. New benzocycloalkylpiperazines, potent and selective 5-HT1A receptor ligands. el Ahmad Y, Laurent E, Maillet P, Talab A, Teste JF, Dokhan R, Tran G, Ollivier R. J Med Chem; 1997 Mar 14; 40(6):952-60. PubMed ID: 9083484 [Abstract] [Full Text] [Related]
31. N-[2-[(substituted chroman-8-yl)oxy]ethyl]-4-(4-methoxyphenyl)butylamines: synthesis and wide range of antagonism at the human 5-HT1A receptor. Yasunaga T, Naito R, Kontani T, Tsukamoto S, Nomura T, Yamaguchi T, Mase T. J Med Chem; 1997 Apr 11; 40(8):1252-7. PubMed ID: 9111299 [Abstract] [Full Text] [Related]
33. Synthesis, dopamine D2 receptor binding studies and docking analysis of 5-[3-(4-arylpiperazin-1-yl)propyl]-1H-benzimidazole, 5-[2-(4-arylpiperazin-1-yl)ethoxy]-1H-benzimidazole and their analogs. Sukalović V, Andrić D, Roglić G, Kostić-Rajacić S, Schrattenholz A, Soskić V. Eur J Med Chem; 2005 May 11; 40(5):481-93. PubMed ID: 15893022 [Abstract] [Full Text] [Related]
34. Differential effects of the 5-hydroxytryptamine (5-HT)1A receptor inverse agonists Rec 27/0224 and Rec 27/0074 on electrophysiological responses to 5-HT1A receptor activation in rat dorsal raphe nucleus and hippocampus in vitro. Corradetti R, Mlinar B, Falsini C, Pugliese AM, Cilia A, Destefani C, Testa R. J Pharmacol Exp Ther; 2005 Oct 11; 315(1):109-17. PubMed ID: 15951403 [Abstract] [Full Text] [Related]
35. Analogues of σ receptor ligand 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) with added polar functionality and reduced lipophilicity for potential use as positron emission tomography radiotracers. Abate C, Niso M, Lacivita E, Mosier PD, Toscano A, Perrone R. J Med Chem; 2011 Feb 24; 54(4):1022-32. PubMed ID: 21229979 [Abstract] [Full Text] [Related]
36. Synthesis of new piperazine-pyridazinone derivatives and their binding affinity toward alpha1-, alpha2-adrenergic and 5-HT1A serotoninergic receptors. Betti L, Zanelli M, Giannaccini G, Manetti F, Schenone S, Strappaghetti G. Bioorg Med Chem; 2006 Apr 15; 14(8):2828-36. PubMed ID: 16376083 [Abstract] [Full Text] [Related]
37. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist. Heinrich JN, Brennan J, Lai MH, Sullivan K, Hornby G, Popiolek M, Jiang LX, Pausch MH, Stack G, Marquis KL, Andree TH. Eur J Pharmacol; 2006 Dec 15; 552(1-3):36-45. PubMed ID: 17056032 [Abstract] [Full Text] [Related]
40. Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes. Quaglia W, Pigini M, Piergentili A, Giannella M, Marucci G, Poggesi E, Leonardi A, Melchiorre C. J Med Chem; 1999 Jul 29; 42(15):2961-8. PubMed ID: 10425105 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]